Real-world study of biologics for nasal polyps
Treatments studied
Part of Ear, nose & throat clinical trials.
This study follows people with chronic rhinosinusitis and nasal polyps who are starting a biologic medication (omalizumab, mepolizumab, or dupilumab) to see how well it works in real life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with chronic rhinosinusitis with nasal polyps (CRSwNP).
- You meet the approval criteria for your prescribed biologic (omalizumab, mepolizumab, or dupilumab).
- You have not used another biologic therapy in the last 3 months before starting the current one.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with chronic rhinosinusitis with nasal polyps (CRSwNP)—a condition causing blocked sinuses and nasal growths—who are starting a new biologic medication called tezepelumab. Researchers will track how symptoms and quality of life improve over time in everyday medical practice.
This study collects information from people with chronic rhinosinusitis and nasal polyps in both nostrils. By tracking patients over time, researchers hope to learn more about the condition and how to improve care.
This study is testing whether certain markers in your blood can predict how well biologic injections (medicines that reduce inflammation) will work for chronic sinusitis with nasal polyps. You'll continue your regular nasal spray and may receive a biologic or a placebo (a shot with no medicine) to see if it improves your symptoms.
This study compares two ways to treat chronic sinusitis with nasal polyps: giving a medicine that targets a specific type of inflammation (anti-IL-5 therapy) along with simple removal of polyps, versus a more extensive sinus surgery. The goal is to see which approach better controls your symptoms and reduces the need for repeat treatment.
This study looks for certain markers in your blood and nasal tissue that may be linked to chronic sinusitis with nasal polyps. It may help doctors understand the condition better and could lead to more targeted treatments in the future.
This trial tests a new injectable medicine (lebrikizumab) for people with chronic sinusitis and nasal polyps that steroid treatments haven't controlled. It aims to reduce polyp size and improve breathing, smell, and congestion.
Hear when a new Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.